Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Alan S. Coates, Binghe Xu, Andrew Tutt et al.|Annals of Oncology|2015Cited by 1.8k
Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VIIDiana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al.|Journal of Clinical Oncology|2000Cited by 295
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?Stefan Aebi, Aron Goldhirsch, Shari Gelber et al.|The Lancet|2000Cited by 286
Identifying Breast Cancer Patients at High Risk for Bone MetastasesMarco Colleoni, Anne O’Neill, Richard D. Gelber et al.|Journal of Clinical Oncology|2000Cited by 125
Prognostic importance of thymidylate synthase expression in early breast cancer.Bernhard C. Pestalozzi, Patrick G. Johnston, Harriet F. Peterson et al.|Journal of Clinical Oncology|1997Cited by 124